COVID-19 treatment: Roche’s antibody cocktail explained; why it is approved in India
The antibody cocktail is expected to be administered among patients who are at a high risk of developing a severe form of COVID-19 infection. Last week, drug firm Roche India received approvals for the Emergency Use Authorisation (EUA) from the Central Drugs Standards Control Organisation (CDSCO) for the antibody cocktail to be used in treatment … Read more
